| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/07/2015 | CN102574927B 产生抗甲基化dna抗体的杂交瘤及其利用 Production of anti-methylated dna antibody-producing hybridomas and use |
| 01/07/2015 | CN102459342B 用于治疗血液肿瘤的抗il-3ra抗体 For the treatment of blood cancer antibody anti-il-3ra |
| 01/07/2015 | CN102245641B 抗pcsk9的高亲和力人抗体 Pcsk9 high affinity anti-human antibodies |
| 01/07/2015 | CN102203133B 人巨细胞病毒中和抗体及其应用 HCMV neutralizing antibody and its application |
| 01/07/2015 | CN102046658B 白介素-4受体α(IL-4Rα)-173的结合成员 Interleukin-4 receptor α (IL-4Rα) -173 binding members of |
| 01/07/2015 | CN101851289B H5亚型禽流感病毒血凝素蛋白的人源化抗体及其用途 H5 subtype avian influenza virus hemagglutinin protein of humanized antibodies and their uses |
| 01/07/2015 | CN101330923B 治疗性疫苗 Therapeutic vaccines |
| 01/06/2015 | US8927810 Optimizing glycan processing in plants |
| 01/06/2015 | US8927697 PD-1 specific antibodies and uses thereof |
| 01/06/2015 | US8927696 Humanized anti-human CD34 monoclonal antibody and uses thereof |
| 01/06/2015 | US8927695 Protein-based assays for screening of the IgE-receptor interaction |
| 01/06/2015 | US8927694 Human serum albumin linkers and conjugates thereof |
| 01/06/2015 | US8927689 Peptide nanostructures and methods of generating and using the same |
| 01/06/2015 | US8927503 Modulations of protease activated receptors |
| 01/06/2015 | US8927492 Fibroblast growth factor 21 proteins |
| 01/06/2015 | US8927485 Site-specific modification of proteins through chemical modification enabling protein conjugates, protein dimer formation, and stapled peptides |
| 01/06/2015 | US8927288 Phage antibodies to radiation-inducible neoantigens |
| 01/06/2015 | US8927233 Fusion polypeptides capable of activating receptors |
| 01/06/2015 | US8927225 Human catechol-O-methyltransferase (COMT) assay |
| 01/06/2015 | US8927220 Method for diagnosing immunoglobulin A nephropathy and TGBM nephropathy |
| 01/06/2015 | US8927206 Virus causing respiratory tract illness in susceptible mammals |
| 01/06/2015 | US8927205 Recombinant polypeptides of the members of the TNF ligand family and use thereof |
| 01/06/2015 | US8926995 Adjuvant |
| 01/06/2015 | US8926983 Method for improving memory in AD patients |
| 01/06/2015 | US8926982 Reagents and methods for detecting influenza virus proteins |
| 01/06/2015 | US8926979 Treatment of cancer or pre-malignant conditions using anti-CD40 antibodies |
| 01/06/2015 | US8926978 Antibodies directed against nerve growth factor (NGF) |
| 01/06/2015 | US8926977 Antibodies to the E1 extracellular loop of ion channels |
| 01/06/2015 | US8926976 Modulators |
| 01/06/2015 | US8926975 Method of treating ankylosing spondylitis |
| 01/06/2015 | US8926974 Methods of treating a tauopathy |
| 01/06/2015 | US8926973 Reducing the immunogenicity of fusion proteins |
| 01/06/2015 | US8926971 Humanized anti-CCR2 antibodies and methods of use therefor |
| 01/06/2015 | US8926970 Rspondin antibodies as inhibiting factors of angiogenesis and vaculogenesis |
| 01/06/2015 | US8926969 Anti-CD38 antibodies |
| 01/06/2015 | US8926966 Cloned glutamic acid decarboxylase |
| 01/06/2015 | US8926957 Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells |
| 01/06/2015 | US8926956 Antibody recognizing human leukemia inhibitory factor (LIF) |
| 01/06/2015 | US8926946 Peptides for transport of therapeutics and their carriers in mouse models and humans |
| 01/06/2015 | CA2630771C Protein constructs designed for targeting and lysis of cells |
| 01/06/2015 | CA2585196C Anti-glypican 3 antibody having modified sugar chain |
| 01/06/2015 | CA2552553C Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer |
| 01/06/2015 | CA2541671C Bispecific antibody substituting for functional proteins |
| 01/06/2015 | CA2507080C Humanized antibodies against monocyte chemotactic proteins |
| 01/06/2015 | CA2477935C Multivalent constructs for therapeutic and diagnostic applications |
| 01/06/2015 | CA2477195C Deleted sequence in m. tuberculosis, method for detecting mycobacteria using these sequences and vaccines |
| 01/01/2015 | US20150005477 Compositions and methods for conjugating activatable antibodies |
| 01/01/2015 | US20150005476 Process for enriching iga |
| 01/01/2015 | US20150005475 Process for reducing antibody aggregate levels and antibodies produced thereby |
| 01/01/2015 | US20150005474 Recognition molecules for the treatment and detection of tumors |
| 01/01/2015 | US20150005226 Antibodies That Inhibit TSLP Activity |
| 01/01/2015 | US20150004700 Rationally designed antibodies |
| 01/01/2015 | US20150004623 Diagnostic kit for the detection of early acute leptospirosis |
| 01/01/2015 | US20150004618 Method for linking and characterising linked nucleic acids, e.g. antibody encoding nucleic acids, in a composition |
| 01/01/2015 | US20150004608 Monocyte-derived nucleic acids and related compositions and methods |
| 01/01/2015 | US20150004185 Prion disease-specific epitopes and methods of use thereof |
| 01/01/2015 | US20150004183 Novel Anti-Malignant Tumor Agent |
| 01/01/2015 | US20150004178 Anti-human sema4a antibodies useful to treat disease |
| 01/01/2015 | US20150004177 Monoclonal antibodies against cd32b |
| 01/01/2015 | US20150004176 Regulatory t cells and methods of identifying, obtaining and using to treat immuno-based disorders |
| 01/01/2015 | US20150004174 Methods for treating homozygous familial hypercholesterolemia |
| 01/01/2015 | US20150004173 Compositions and methods for analyzing histidine phosphorylation |
| 01/01/2015 | US20150004172 Hypoxia-induced mitogenic factor |
| 01/01/2015 | US20150004171 Pharmaceutical composition for treatment and/or prevention of cancer |
| 01/01/2015 | US20150004170 Angiogenic and Immunologic Applications of Anti-CD160 Specific Compounds Obtainable From mAb CL1-R2 |
| 01/01/2015 | US20150004169 Methods of Treating Brain Injury |
| 01/01/2015 | US20150004168 Lectin-like oxidized ldl receptor 1 antibodies and methods of use |
| 01/01/2015 | US20150004167 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 01/01/2015 | US20150004166 Bispecific anti-vegf/anti-ang-2 antibodies |
| 01/01/2015 | US20150004165 Secreted proteins |
| 01/01/2015 | US20150004164 Use Of Antibody |
| 01/01/2015 | US20150004163 Adjuvant combinations comprising an nkt activator, a cd40 agent, cd40 agonist, and optional antigen, the use through inducing synergistic cellular immunity |
| 01/01/2015 | US20150004162 Surrogate binding proteins |
| 01/01/2015 | US20150004160 Methods and compositions for increasing iduronate 2-sulfatase activity in the cns |
| 01/01/2015 | US20150004159 Screening for anti-cancer compounds using netrin-1 activity |
| 01/01/2015 | US20150004157 Osteopontin isoform a inhibitors and methods of use |
| 01/01/2015 | US20150004155 Rsv g protein specific antibodies |
| 01/01/2015 | US20150004136 Responsiveness to angiogenesis inhibitors |
| 01/01/2015 | US20150004133 Compositions And Methods For Treating Steatohepatitis, Liver Fibrosis, and Hepatocellular Carcinoma (HCC) |
| 01/01/2015 | US20150004129 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 12/31/2014 | CN104254544A Cdim结合蛋白及其用途 Cdim binding protein and its use |
| 12/31/2014 | CN104254543A 用免疫球蛋白治疗粘膜炎 Immunoglobulin treatment of mucositis |
| 12/31/2014 | CN104254542A 包含分泌-样免疫球蛋白的组合物 Contains secretion - like immunoglobulin composition |
| 12/31/2014 | CN104250649A 皮肤角化-少毛-白甲综合征新的致病基因及其编码蛋白质和应用 Skin keratinocytes - less hair - white syndrome A new disease genes and their encoded proteins and application |
| 12/31/2014 | CN104250637A 一株禽流感h9n2亚型病毒株及其应用 H9n2 virus subtype strain of avian flu strains and its application |
| 12/31/2014 | CN104250635A 14型肺炎球菌中和性单克隆抗体及其应用 Neutralizing monoclonal antibody pneumococcal type 14 and its application |
| 12/31/2014 | CN104250302A 抗pd-1抗体及其应用 Anti-pd-1 antibody and uses thereof |
| 12/31/2014 | CN104250301A 工程化抗体恒定结构域分子 Engineered antibody constant domain molecules |
| 12/31/2014 | CN104250292A 一种杆菌肽抗原制备方法及其应用 An antigen preparation bacitracin and its application |
| 12/31/2014 | CN103408667B 胱抑素c纳米抗体及其编码序列 Cystatin c Nanobody its coding sequence |
| 12/31/2014 | CN103173419B 抗趋化因子4单克隆抗体、杂交瘤细胞系及应用 4 monoclonal anti-chemokine antibodies, hybridoma cell line and application |
| 12/31/2014 | CN103172525B 一种乙基香兰素抗原和抗体的制备方法及其应用 An ethyl vanillin antigen and antibody preparation method and its application |
| 12/31/2014 | CN103087188B 免疫球蛋白级分及其方法 Immunoglobulin fractions and methods |
| 12/31/2014 | CN102924598B 抗体 Antibody |
| 12/31/2014 | CN102898522B 具有抗肿瘤活性的四氢吡啶并吡喃-单克隆抗体cd14结合物及其制备方法和应用 With anti-tumor activity tetrahydropyrido pyran - cd14 monoclonal antibody conjugates and its preparation method and application |
| 12/31/2014 | CN102827813B 抗人cd133单克隆抗体及其制备和应用 Cd133 anti-human monoclonal antibody and its preparation and application |
| 12/31/2014 | CN102712692B Rsv-特异性结合分子 Rsv- specific binding molecule |
| 12/31/2014 | CN102643332B 人pct的b细胞表位肽段及其单克隆抗体的应用 B-cell epitope peptides and monoclonal antibodies were pct Applications |
| 12/31/2014 | CN102245640B 抗-pd-l1抗体及它们用于增强t细胞功能的用途 Use anti -pd-l1 antibodies and they are used to enhance the t-cell function |
| 12/31/2014 | CN102239180B 抗ccr2抗体 Antibody anti ccr2 |